Views & Analysis Digital health round-up – Fitbit’s smartwatch acquisition A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Digital Health Round-up: Fitbit falters, NHS picks six winne... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Digital Health Round-up – Watson’s synthetic biology venture... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Digital Health Round-up – the NHS’ digitisation; worldwide w... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Digital health round-up – Rio Olympics; AZ’s digital plans A round-up of this week’s top digital healthcare news.
Views & Analysis Digital health round-up: Fitbit prepares; Nestlé & Samsung t... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.